株式会社極東書店トップ商品一覧Wastewater Analysis for Substance Abuse Monitoring and Policy Development.

商品詳細

Wastewater Analysis for Substance Abuse Monitoring and Policy Development.

Wastewater Analysis for Substance Abuse Monitoring and Policy Development.

・ISBN 978-0-367-61253-5 paper GB£ 50.99

¥16,153.- (税込) (※)価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。

お気に入り
電子版あり 大学・学術機関向け電子ブック(eBook)ISBN 9780429025709
著者・編者Prichard, Jeremy / Hall, Wayne / Kirkbride, Paul / O'Brien, Jake,
出版社 (CRC Press, UK)
出版年月2022
ページ数178 pp.
言語ENG
ニュース番号<A00-81957>

解説

This book addresses how to estimate substance use and thereby evaluate policies intended to reduce the harms caused by drugs and other substances. Wastewater analysis (WWA) can provide efficient, affordable, fine-grained and objective data on population substance use trends on a very large scale.

The authors discuss the potential implications of WWA as a new method for understanding substance use in a variety of settings and ignite a discourse with policy makers, criminologists, epidemiologists and other disciplines about the need for collaboration with WWA scientists. The book also features an explanation of the costs and harms of substance use with academic literature from criminological and epidemiological sources and reports from lead agencies.

Additional features include:

  • Details on the origin of wastewater analysis in environmental science
  • Description of analytical chemistry methods for tracing a wide variety of substances, including illicit drugs, alcohol, tobacco and other chemicals
  • Exploration of the major empirical problems in estimating population consumption of alcohol, tobacco and drugs at the international and national level
  • Examination of the principles of human research ethics and their application to wastewater analysis

Wastewater Analysis for Substance Abuse Monitoring and Policy Development is a valuable tool for analytical chemists, wastewater scientists and criminologists, as well as researchers and policy makers across disciplines who work in drug sectors.